Preferential accumulation of the active S-(+) isomer in murine retina highlights novel mechanisms of vigabatrin-associated retinal toxicity.


Journal

Epilepsy research
ISSN: 1872-6844
Titre abrégé: Epilepsy Res
Pays: Netherlands
ID NLM: 8703089

Informations de publication

Date de publication:
02 2021
Historique:
received: 29 09 2020
revised: 27 11 2020
accepted: 15 12 2020
pubmed: 2 1 2021
medline: 10 2 2022
entrez: 1 1 2021
Statut: ppublish

Résumé

((S)-(+)/(R)-(-)) vigabatrin (Sabril

Identifiants

pubmed: 33385945
pii: S0920-1211(20)30587-8
doi: 10.1016/j.eplepsyres.2020.106536
pmc: PMC7897276
mid: NIHMS1657513
pii:
doi:

Substances chimiques

Anticonvulsants 0
4-Aminobutyrate Transaminase EC 2.6.1.19
Vigabatrin GR120KRT6K

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

106536

Subventions

Organisme : NEI NIH HHS
ID : R01 EY027476
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Références

Neurochem Int. 2016 Oct;99:72-84
pubmed: 27311541
Neuroscience. 1993 Nov;57(2):473-82
pubmed: 7906874
Epilepsia. 1996 Aug;37(8):803-5
pubmed: 8764822
Glia. 2001 Apr 1;34(1):27-38
pubmed: 11284017
Epileptic Disord. 2003 Mar;5(1):51-6
pubmed: 12773297
Acta Neurol Scand Suppl. 2011;(192):5-15
pubmed: 22061176
Seizure. 2001 Oct;10(7):505-7
pubmed: 11749107
Neurotoxicology. 1989 Spring;10(1):15-28
pubmed: 2570388
Neurochem Int. 2019 May;125:151-162
pubmed: 30822440
Neurochem Res. 1988 Jan;13(1):69-75
pubmed: 2897088
Expert Opin Pharmacother. 2016 Jun;17(8):1091-101
pubmed: 26933940
Amino Acids. 2012 Nov;43(5):1979-93
pubmed: 22476345
AAPS PharmSciTech. 2020 Jul 14;21(5):196
pubmed: 32666325
Exp Toxicol Pathol. 2015 Jan;67(1):13-20
pubmed: 25446799
Epilepsy Res. 2010 Nov;92(1):48-53
pubmed: 20850272
Pharmacol Res Perspect. 2019 Jan 07;7(1):e00456
pubmed: 30631446
Neuron. 1989 Jun;2(6):1547-58
pubmed: 2576375
Epilepsy Curr. 2018 Jul-Aug;18(4 Suppl 1):1-26
pubmed: 30233275
Br J Pharmacol. 2006 Feb;147(3):298-306
pubmed: 16331283
Cell Physiol Biochem. 2016;40(5):831-846
pubmed: 27941319

Auteurs

Dana C Walters (DC)

Department of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA.

Erwin E W Jansen (EEW)

Department of Clinical Chemistry, Metabolic Unit, VU University Medical Center & Amsterdam Neuroscience, Amsterdam, the Netherlands.

Gajja S Salomons (GS)

Department of Clinical Chemistry, Metabolic Unit, VU University Medical Center & Amsterdam Neuroscience, Amsterdam, the Netherlands.

Erland Arning (E)

Baylor Scott & White Research Institute, Institute of Metabolic Disease, Dallas, TX, USA.

Paula Ashcraft (P)

Baylor Scott & White Research Institute, Institute of Metabolic Disease, Dallas, TX, USA.

Teodoro Bottiglieri (T)

Baylor Scott & White Research Institute, Institute of Metabolic Disease, Dallas, TX, USA.

Jean-Baptiste Roullet (JB)

Department of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA.

K Michael Gibson (KM)

Department of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA. Electronic address: mike.gibson@wsu.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH